ArticleBMC infectious diseases2026
Maxillofacial tubercular osteomyelitis: diagnostic and therapeutic perspectives from a case series.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionExtrapulmonary tuberculosis (TB) contributes significantly to the disease burden in Southeast Asia, yet maxillofacial involvement is rare and often misdiagnosed due to nonspecific features such as swelling, ulceration, or trismus. Conventional microbiology shows low sensitivity in these paucibacillary lesions, emphasizing the role of rapid molecular tests such as Cartridge-Based Nucleic Acid Amplification Testing (CBNAAT). This case series outlines the diagnostic challenges of maxillofacial TB in an endemic region. Nine patients (aged 9-33 years) presented with chronic lesions in maxillofacial region. Imaging commonly demonstrated osteolysis, cortical breach, periosteal reaction, or soft-tissue abscess. Mantoux testing, cytology, and Ziehl-Neelsen staining were often inconclusive, whereas CBNAAT or culture confirmed Mycobacterium tuberculosis in most cases. All patients received standard anti-tubercular therapy with significant clinical and radiographic improvement.
conclusionMaxillofacial TB should be considered in persistent jaw lesions. Early molecular testing enhances diagnosis and supports timely, effective therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.